Project description
A revolutionary technology for genetic and epigenetic data analysis
Epigenetic modifications play vital roles in biology, from early embryonic development to defence mechanisms and cancer. However, current sequencing technologies fail to read the majority of these modifications. To address this limitation, the scientists of the EU-funded CONAN II project have developed the single-molecule magnetic detection and quantification (SIMDEQ) proprietary technology that in addition to genetic data it can read the chemical signatures on both DNA and RNA. During the CONAN II project, scientists developed a fully functional high-throughput system suitable for commercialisation. The SIMDEQ technology fosters a new genomics approach and has the potential to revolutionise genetic and epigenetic analysis studies.
Fields of science
Programme(s)
Funding Scheme
SME-2 - SME instrument phase 2
Coordinator
75014 Paris
France
See on map